Beginning Cash: The amount of cash reported by the company on its previous statement.
Aptose Biosciences, Inc. (APTOF) had Beginning Cash of $6.71M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-25.47M |
|
-- |
|
-- |
|
$24.72M |
|
$-24.72M |
|
$-0.74M |
|
$-25.47M |
|
$-25.47M |
|
$-25.47M |
|
$-25.47M |
|
$-25.47M |
|
$-25.47M |
|
$-24.72M |
|
$-24.70M |
|
2.45M |
|
2.45M |
|
$-10.41 |
|
$-10.41 |
|
| Balance Sheet Financials | |
$6.45M |
|
$0.00M |
|
$3.57M |
|
$10.01M |
|
$9.31M |
|
$27.02M |
|
$27.87M |
|
$37.18M |
|
$-27.17M |
|
$-27.17M |
|
$-27.17M |
|
2.55M |
|
| Cash Flow Statement Financials | |
$-21.99M |
|
-- |
|
$19.38M |
|
|
Beginning Cash |
$6.71M |
$4.10M |
|
$-2.61M |
|
$0.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.69 |
|
-- |
|
-- |
|
-181.33 |
|
-0.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
93.75% |
|
93.75% |
|
-254.37% |
|
17092.60% |
|
$-10.64 |
|
$-8.99 |
|
$-8.99 |
|